Riskpilot← Back to searchSign inGet full accessR&R Diagnostic AB
ABActiveOrg 5592496375Solvägen 36Medical specialists activities · NACE 8622Est. 20200 employees
Revenue 2025
SEK 170K
-59% vs 2024
EBITDA margin
60.7%
-66% vs 2024
Equity ratio
97.8%
Financial strength
Net profit 2025
SEK 76K
-68% vs 2024
| Revenue | SEK 170K | -59% |
| EBITDA | SEK 103K | -66% |
| Net profit | SEK 76K | -68% |
| Total assets | SEK 1,1M | -12% |
| Equity | SEK 1,1M | -11% |
| Employees | 0 | — |
Legal name
R&R Diagnostic AB
Org number
5592496375
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
24 mars 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall arbeta med radiologisk samt reumatologisk diagnostik och behandling, undervisningsuppdrag, samt konsultverksamhet inom försäkringsmedicin och därmed förenlig verksamhet.
Address
Solvägen 36
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 627 | 737 | 709 | 416 | 170 |
| Staff expenses | — | — | — | −29 | −2 |
| EBITDA | 527 | 662 | 581 | 302 | 103 |
| Depreciation & amort. | −0 | −10 | −0 | — | — |
| EBIT | 527 | 652 | 581 | 302 | 103 |
| Net financials | — | −2 | −3 | −4 | −5 |
| Profit before tax | 527 | 650 | 579 | 298 | 98 |
| Tax | −109 | −135 | −120 | −61 | −22 |
| Net profit | 418 | 515 | 459 | 237 | 76 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 852 | 1 241 | 1 213 | 1 216 | 1 075 |
| Equity | 739 | 1 071 | 1 147 | 1 179 | 1 051 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 113 | 171 | 66 | 36 | 24 |
| Total debt | 113 | 171 | 66 | 36 | 24 |
EBITDA margin
60.7%
This company
15.8%
Market median
+284% vs market
20212025
Equity ratio
97.8%
This company
38.2%
Market median
+156% vs market
20212025
Return on equity
7.2%
This company
18.4%
Market median
-61% vs market
20212025
Net profit margin
44.8%
This company
8.1%
Market median
+453% vs market
20212025
Asset turnover
0.16×
This company
1.12×
Market median
-86% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of R&R Diagnostic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Lennart Engström | Deputy Board Member | 0 companies |
| Karin Margareta Hellgren | Board of Directors | 0 companies |